David Chéreau - Concepedia

Concepedia

Author

David Chéreau

Boston Biomedical Research Institute

Also Known As

Chereau, D., D CHEREAU, D. Chereau, David Chereau, David Chéreau

19

Publications

1.3K

Citations

13

H-Index

39

Concepts

All Affiliations

Boston Biomedical Research Institute Sunesis (United States)University of Pennsylvania Idera Pharmaceuticals (United States)Yale University

DC

About

David Chéreau is an author at Boston Biomedical Research Institute specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Cell Biology	8	8	1.1K
3	Natural Sciences	6	6	742
4	Biochemistry	2	2	124
5	Social Sciences	1	1	266

David Chéreau

×

13

Publications

1.3K

Citations

13

H-Index

	Year	Citations
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System Kelly J. Inglis, David Chéreau, Elizabeth Brigham, Journal of Biological Chemistry Neurodegenerative DiseasesSerine 129Molecular NeuroscienceSignal TransductionPolo-like Kinase 2	2008	266
Actin-bound structures of Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly David Chéreau, Frédéric Kerff, Philip Graceffa, Proceedings of the National Academy of Sciences Protein AssemblyMolecular BiologyCytoskeletonMulti-protein AssemblyCell Signaling	2005	258
Leiomodin Is an Actin Filament Nucleator in Muscle Cells David Chéreau, Małgorzata Boczkowska, Aneta Skwarek‐Maruszewska, Science Muscle PhysiologyMuscle CellsMolecular PhysiologySignal TransductionSkeletal Muscle	2008	249
Structural Basis for the Actin-Binding Function of Missing-in-Metastasis Sung Haeng Lee, Frédéric Kerff, David Chéreau, Structure Structural BasisCytoskeletonCell MotilityMedicineCell Biology	2007	151
Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein Katerina Levitan, David Chéreau, Samuel I. A. Cohen, Journal of Molecular Biology Profound InfluenceBiochemistryNatural SciencesMolecular BiologyBiophysics	2011	102
Understanding the role of the G-actin-binding domain of Ena/VASP in actin assembly David Chéreau, Roberto Domínguez Journal of Structural Biology Protein FunctionMolecular PhysiologySignal TransductionProtein AssemblyG Protein-coupled Receptor	2006	78
Structural and Functional Analysis of Caspase Active Sites David Chéreau, Lalitha Kodandapani, Kevin J. Tomaselli, Biochemistry	2003	51
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration Gary D. Probst, Simeon Bowers, Jennifer M. Sealy, Bioorganic & Medicinal Chemistry Letters MedicineCell DeathNeuropharmacologyNeuroprotectionNeurology	2010	44
Cortactin Binding to F-actin Revealed by Electron Microscopy and 3D Reconstruction Kiran Pant, David Chéreau, Victoria Hatch, Journal of Molecular Biology Protein FunctionElectron MicroscopyNatural SciencesCell AdhesionMolecular Biology	2006	33
The actin‐binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F‐actin Alexander Shvetsov, Emir Berkane, David Chéreau, Cell Motility and the Cytoskeleton	2008	27

Page 1